profile picture of Stuart Rich

Stuart Rich

Director, Bluhm Cardiovascular institute Pulmonary Vascular Disease Program.

Northwestern University

United States

Areas of Expertise

Right Heart Failure

The PVRI has established itself as the only professional organization that is devoted exclusively towards addressing the field of pulmonary vascular diseases. To me, the greatest attribute of the PVRI has been its success with the annual scientific congress by bringing physicians from around the world, and from diverse areas of expertise, into a common arena to facilitate collaboration. The PVRI is responsible for contributing to progress more than people can appreciate.


Dr. Stuart Rich MD is a cardiologist and Director of Northwestern Medicine’s Pulmonary Vascular Disease Programme at the Bluhm Cardiovascular Institute and a Professor of Medicine, Northwestern University Feinberg School of Medicine.

He is one of the world’s most recognised experts on pulmonary vascular diseases. For more than three decades he has dedicated his research and clinical efforts to finding better solutions for pulmonary hypertension.

Dr. Rich completed his residency training in medicine at Washington University in St. Louis, and fellowship in cardiology at the University of Chicago. His career began at the University of Illinois where he was principal investigator for the National Institutes of Health (NIH) Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the U.S. for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted cutting-edge research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease and been at the forefront of the development of virtually every new treatment for pulmonary hypertension, as well as the use of therapeutic procedures and devices. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI